Articles, guides, and regulatory updates from our community.
New research reveals how thymosin alpha 1 immune modulation may help combat HIV latency through IL-15 pathway activation in laboratory studies.
By Peptide Association Research Team
New research reveals thymosin alpha 1 immune therapy combined with IL-15 may help reverse immune cell aging in hepatocellular carcinoma. Learn the implications.
By Peptide Association Research Team